| Product Code: ETC10402135 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of recombinant hormones to Cyprus experienced significant growth in 2024, with top exporting countries being Metropolitan France, Belgium, Denmark, UK, and USA. The market concentration, as measured by the HHI, increased from high to very high in 2024, indicating a more concentrated market. The impressive compound annual growth rate (CAGR) of 110.54% from 2020 to 2024 highlights the robust expansion of this market segment. Moreover, the notable growth rate of 52.24% from 2023 to 2024 suggests accelerating momentum in the import of recombinant hormones to Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Recombinant Hormone Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Recombinant Hormone Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Recombinant Hormone Market - Industry Life Cycle |
3.4 Cyprus Recombinant Hormone Market - Porter's Five Forces |
3.5 Cyprus Recombinant Hormone Market Revenues & Volume Share, By Hormone Type, 2021 & 2031F |
3.6 Cyprus Recombinant Hormone Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Cyprus Recombinant Hormone Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 Cyprus Recombinant Hormone Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Recombinant Hormone Market Trends |
6 Cyprus Recombinant Hormone Market, By Types |
6.1 Cyprus Recombinant Hormone Market, By Hormone Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Recombinant Hormone Market Revenues & Volume, By Hormone Type, 2021 - 2031F |
6.1.3 Cyprus Recombinant Hormone Market Revenues & Volume, By Insulin, 2021 - 2031F |
6.1.4 Cyprus Recombinant Hormone Market Revenues & Volume, By Growth Hormone, 2021 - 2031F |
6.1.5 Cyprus Recombinant Hormone Market Revenues & Volume, By Erythropoietin, 2021 - 2031F |
6.2 Cyprus Recombinant Hormone Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Recombinant Hormone Market Revenues & Volume, By Diabetes Management, 2021 - 2031F |
6.2.3 Cyprus Recombinant Hormone Market Revenues & Volume, By Growth Disorders, 2021 - 2031F |
6.2.4 Cyprus Recombinant Hormone Market Revenues & Volume, By Anemia Treatment, 2021 - 2031F |
6.3 Cyprus Recombinant Hormone Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Recombinant Hormone Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.3 Cyprus Recombinant Hormone Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.3.4 Cyprus Recombinant Hormone Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
7 Cyprus Recombinant Hormone Market Import-Export Trade Statistics |
7.1 Cyprus Recombinant Hormone Market Export to Major Countries |
7.2 Cyprus Recombinant Hormone Market Imports from Major Countries |
8 Cyprus Recombinant Hormone Market Key Performance Indicators |
9 Cyprus Recombinant Hormone Market - Opportunity Assessment |
9.1 Cyprus Recombinant Hormone Market Opportunity Assessment, By Hormone Type, 2021 & 2031F |
9.2 Cyprus Recombinant Hormone Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Cyprus Recombinant Hormone Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 Cyprus Recombinant Hormone Market - Competitive Landscape |
10.1 Cyprus Recombinant Hormone Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Recombinant Hormone Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |